Insomnia During Menopause

Sleep Laboratory Studies on Insomnia Associated With Postmenopausal Syndrome and Hormone Replacement Therapy
  • Gerda Saletu-Zyhlarz
  • Peter Anderer
  • Georg Gruber
  • Markus Metka
  • Johannes Huber
  • Elisabeth Grätzhofer
  • Bernd Saletu
Part of the Current Clinical Neurology book series (CCNEU)


Sleep disturbance is a prevalent health problem (1, 2, 3) that occurs more frequently in women than in men (2,4, 5, 6). Insomnia increases particularly as women approach and pass through menopause (7, 8, 9, 10). Insomnia in postmenopausal women, part of the climacteric syndrome, can occur, on the one hand, in association with hormonal changes (11,12); on the other hand, women are more likely to suffer from psychiatric disorders, such as major depression and anxiety disorders, which are also correlated with insomnia (5,13). Organic sleep disorders such as sleep-disordered breathing (SDB) resulting from a decrease of sex hormones in menopause may play an important role as well (14).


Obstructive Sleep Apnea Sleep Quality Pittsburgh Sleep Quality Index Subjective Sleep Quality Estradiol Valerate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hochstrasser, B., [Epidemiology of sleep disorders]. Ther Umsch, 1993;50(10):679–683.PubMedGoogle Scholar
  2. 2.
    Ohayon, M.M. and T. Roth, What are the contributing factors for insomnia in the general population? J Psychosom Res, 2001;51(6): 45–755.CrossRefGoogle Scholar
  3. 3.
    Zeitlhofer, J., A. Rieder, G. Kapfhammer, et al., [Epidemiology of sleep disorders in Austria]. Wien Klin Wochenschr, 1994;106(3):86–88.PubMedGoogle Scholar
  4. 4.
    Brugge, K., D. Kripke, S. Ancoli-Israel, and L. Garfinkel, The association of menopausal status and age with sleep. Sleep Res, 1989;18:208.Google Scholar
  5. 5.
    Owens, J.F. and K.A. Matthews, Sleep disturbance in healthy middle-aged women. Maturitas, 1998;30(1):41–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Saletu, B., N. Brandstatter, R. Frey, et al., [Clinical aspects of sleep disorders-experiences with 817 patients of an ambulatory sleep clinic; comment]. Wien Klin Wochenschr, 1997;109(11):390–399.PubMedGoogle Scholar
  7. 7.
    Kravitz, H.M., P.A. Ganz, J. Bromberger, L.H. Powell, K. Sutton-Tyrrell, and P.M. Meyer, Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause, 2003;10(1):19–28.PubMedGoogle Scholar
  8. 8.
    Kuh, D.L., M. Wadsworth, and R. Hardy, Women’s health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol, 1997;104(8):923–933.PubMedGoogle Scholar
  9. 9.
    Lugaresi, E., F. Cirignotta, and M. Zucconi, Good and poor sleepers: an epidemiological survey of San Marino population. In: Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution (C. Guilleminault and E. Lugaresi, eds.). Raven Press: New York, 1983.Google Scholar
  10. 10.
    Shaver, J.L. and S.N. Zenk, Sleep disturbance in menopause. J Womens Health Gend Based Med, 2000;9(2):109–118.PubMedCrossRefGoogle Scholar
  11. 11.
    Manber, R. and R. Armitage, Sex, steroids, and sleep: a review. Sleep, 1999;22(5):540–555.PubMedGoogle Scholar
  12. 12.
    Moline, M., L. Broch, and R. Zak, Sleep problems across the life cycle in women. Curr Treat Options Neurol, 2004;6(4):319–330.PubMedCrossRefGoogle Scholar
  13. 13.
    Krystal, A.D., Insomnia in women. Clin Cornerstone, 2003;5(3):41–50.PubMedCrossRefGoogle Scholar
  14. 14.
    Guilleminault, C., L. Palombini, D. Poyares, and S. Chowdhuri, Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort. J Psychosom Res, 2002;53(1):611–615.PubMedCrossRefGoogle Scholar
  15. 15.
    Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry, 1979;136(10):1257–1262.PubMedGoogle Scholar
  16. 16.
    Hunter, M., R. Battersby, and M. Whitehead, Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas, 1986;8(3):217–228.PubMedCrossRefGoogle Scholar
  17. 17.
    Karacan, I., J.I. Thornby, M. Anch, et al., Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med, 1976;10(5):239–244.PubMedCrossRefGoogle Scholar
  18. 18.
    Welstein, L., W. Dement, D. Redington, C. Guilleminault, and M. Mitler, Insomnia in the San Francisco Bay area: a telephone survey. In: Sleep/Wake Disorders: Natural History, Epidemiology and Long-Term Evolution, (C. Guilleminault, ed.), New York: Raven Press, 1983:73–85.Google Scholar
  19. 19.
    Moe, K.E., Reproductive hormones, aging, and sleep. Semin Reprod Endocrinol, 1999;17(4):339–348.PubMedCrossRefGoogle Scholar
  20. 20.
    Jean-Louis, G., D.F. Kripke, J.D. Assmus, and R.D. Langer, Sleep-wake patterns among postmenopausal women: a 24-hour unattended polysomnographic study. J Gerontol A Biol Sci Med Sci, 2000;55(3):M120–M123.PubMedGoogle Scholar
  21. 21.
    Asplund, R. and H.E. Aberg, Body mass index and sleep in women aged 40 to 64 years. Maturitas, 1995;22(1):1–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Empson, J.A. and D.W. Purdie, Effects of sex steroids on sleep. Ann Med, 1999;31(2):141–145.PubMedGoogle Scholar
  23. 23.
    Jaszmann, L., N.D. Van Lith, and J.C. Zaat, The peri-menopausal symptoms: the statistical analysis of a survey. Med Gynaecol Sociol, 1969;10:268–277.Google Scholar
  24. 24.
    Ballinger, C.B., Psychiatric morbidity and the menopause; screening of general population sample. Br Med J, 1975;3(5979):344–346.PubMedCrossRefGoogle Scholar
  25. 25.
    Thompson, J. and I. Oswald, Effect of estrogen on the sleep, mood and anxiety of menopausal women. Br Med J, 1977;2:1317–1319.Google Scholar
  26. 26.
    Schiff, I., Q. Regestein, D. Tulchinsky, and K.J. Ryan, Effects of estrogens on sleep and psychological state of hypogonadal women. JAMA, 1979;242(22):2405–2404.PubMedCrossRefGoogle Scholar
  27. 27.
    Erlik, Y., I.V. Tataryn, D.R. Meldrum, P. Lomax, J.G. Bajorek, and H.L. Judd, Association of waking episodes with menopausal hot flushes. JAMA, 1981;245(17):1741–1744.PubMedCrossRefGoogle Scholar
  28. 28.
    Antonijevic, I.A., G.K. Stalla, and A. Steiger, Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol, 2000;182(2):277–282.PubMedCrossRefGoogle Scholar
  29. 29.
    Purdie, D.W., J.A. Empson, C. Crichton, and L. Macdonald, Hormone replacement therapy, sleep quality and psychological wellbeing. Br J Obstet Gynaecol, 1995;102(9):735–739.PubMedGoogle Scholar
  30. 30.
    Polo-Kantola, P., R. Erkkola, H. Helenius, K. Irjala, and O. Polo, When does estrogen replacement therapy improve sleep quality? Am J Obstet Gynecol, 1998;178(5):1002–1009.PubMedCrossRefGoogle Scholar
  31. 31.
    Schulz, H., M. Jobert, K.W. Gee, and D.W. Ashbrook, Soporific effect of the neurosteroid pregnanolone in relation to the substance’s plasma level: a pilot study. Neuropsychobiology, 1996;34(2):106–112.PubMedGoogle Scholar
  32. 32.
    Steiger, A., L. Trachsel, J. Guldner, et al., Neurosteroid pregnenolone induces sleep-EEG changes in man compatible with inverse agonistic GABAA-receptor modulation. Brain Res, 1993;615(2):267–274.PubMedCrossRefGoogle Scholar
  33. 33.
    Teichmann, A.T., Dienogest-Präklinik und Klinik eines neuen Gestagens [Dienogest-Preclinical and Clinical Characteristics of a New Progestin]. Berlin/New York: Walter de Gruyter, 1995.Google Scholar
  34. 34.
    Kupperman, H.S., B.B. Wetchler, and M.H. Blatt, Contemporary therapy of the menopausal syndrome. JAMA, 1959;171:1627–1637.PubMedGoogle Scholar
  35. 35.
    Saletu-Zyhlarz, G., P. Anderer, G. Gruber, et al., Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res, 2003;12(3):239–254.PubMedCrossRefGoogle Scholar
  36. 36.
    Saletu, B., P. Wessely, J. Grünberger, and M. Schulte, Erste klinische Erfahrungen mit einem neuen schlafansto×enden Benzodiazepin, Cinolazepam, mittels eines Selbstbeurteilungsbogens für Schlaf-und Aufwachqualität (SSA). Neuropsychiatrie, 1987;1(4):169–176.Google Scholar
  37. 37.
    Von Zerssen, D., D.M. Koeller, and E.R. Rey, Die Befindlichkeitsskala (B-S)-ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim Forsch Drug Res, 1970;20:915–918.Google Scholar
  38. 38.
    Buysse, D.J., C.F. Reynolds, 3rd, T.H. Monk, S.R. Berman, and D.J. Kupfer, The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res, 1989;28(2):93–213.CrossRefGoogle Scholar
  39. 39.
    Grünberger, J., Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Vienna: Maudrich, 1977.Google Scholar
  40. 40.
    Abt, K., Descriptive data analysis (DDA) in quantitative EEG studies. In: Statistics and Topography in Quantitative EEG (D. Samson-Dollfus et al., eds.). Amsterdam: Elsevier, 1988:150–160.Google Scholar
  41. 41.
    Hunter, M., The south-east England longitudinal study of the climacteric and postmenopause. Maturitas, 1992;14(2):117–126.PubMedCrossRefGoogle Scholar
  42. 42.
    Hunter, M.S., Psychological and somatic experience of the menopause: a prospective study (corrected). Psychosom Med, 1990;52(3):357–367.PubMedGoogle Scholar
  43. 43.
    Kujak, J. and T. Young, The average month-to-month effect of menopausal symptoms on sleep complaints. Sleep, 1997;20(Suppl 1):384.Google Scholar
  44. 44.
    Feinberg, I., M. Braun, and R.L. Koresko, Vertical eye-movement during REM sleep: effects of age and electrode placement. Psychophysiology, 1969;5(5):556–561.PubMedCrossRefGoogle Scholar
  45. 45.
    Tune, G.S., The influence of age and temperament on the adult human sleep-wakefulness pattern. Br J Psychol, 1969;60(4):31–441.Google Scholar
  46. 46.
    Webb, W.B., The different functional relationships of REM and stage 4 sleep. In: The Nature of Sleep (Jovanovic, ed.). Stuttgart: Fischer, 1973:256–258.Google Scholar
  47. 47.
    Rechtschaffen, A. and A. Kales, A Manual of Standardized Terminology, Technique and Scoring System for Sleep Stages. San Francisco: Brain Information Service University of California, 1968.Google Scholar
  48. 48.
    Anderer, P., B. Saletu, and R.D. Pascual-Marqui, Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res, 2000;100(2):81–96.PubMedCrossRefGoogle Scholar
  49. 49.
    Saletu, B., P. Anderer, R. Frey, M. Krupka, and G. Klüsch, Zur Neurophysiologie des Schlafes/ Some remarks about the neurophysiology of sleep. Psychiatria Danubina, 1991;3(1–2):31–58.Google Scholar
  50. 50.
    Dietzel, M., B. Saletu, O.M. Lesch, W. Sieghart, and M. Schjerve, Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. Eur Neurol, 1986;25(Suppl 2):93–103.PubMedGoogle Scholar
  51. 51.
    Reynolds, C.F., 3rd and D.J. Kupfer, Sleep research in affective illness: state of the art circa 1987. Sleep, 1987;10(3):199–215.PubMedGoogle Scholar
  52. 52.
    Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(2):249–260.PubMedCrossRefGoogle Scholar
  53. 53.
    Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001;44(3):139–149.PubMedCrossRefGoogle Scholar
  54. 54.
    Saletu, B., P. Anderer, N. Brandstatter, et al., Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long-versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology, 1994;29(2):69–90.PubMedGoogle Scholar
  55. 55.
    Saletu-Zyhlarz, G., B. Saletu, P. Anderer, et al., Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology, 1997;36(3):117–129.PubMedCrossRefGoogle Scholar
  56. 56.
    Saletu-Zyhlarz, G.M., P. Anderer, P. Berger, G. Gruber, S. Oberndorfer, and B. Saletu, Nonorganic insomnia in panic disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Hum Psychopharmacol, 2000;15(4):241–254.PubMedCrossRefGoogle Scholar
  57. 57.
    Saletu, M., C. Hauer, P. Anderer, et al., [Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]. Wien Klin Wochenschr, 2000;112(6):281–289.PubMedGoogle Scholar
  58. 58.
    Saletu, B., P. Anderer, M. Saletu, et al., Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology, 2000;41(4):181–189.PubMedCrossRefGoogle Scholar
  59. 59.
    Saletu, M., P. Anderer, B. Saletu, et al., Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology, 2000;41(4):190–199.PubMedCrossRefGoogle Scholar
  60. 60.
    Saletu, M., P. Anderer, B. Saletu, et al., Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole. Hum Psychopharmacol, 2001;16(2):177–187.PubMedCrossRefGoogle Scholar
  61. 61.
    Montplaisir, J., J. Lorrain, R. Denesle, and D. Petit, Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause, 2001;8(1):10–16.PubMedCrossRefGoogle Scholar
  62. 62.
    Polo-Kantola, P., R. Erkkola, K. Irjala, S. Pullinen, I. Virtanen, and O. Polo, Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril, 1999;71(5):873–880.PubMedCrossRefGoogle Scholar
  63. 63.
    Pickett, C.K., J.G. Regensteiner, W.D. Woodard, D.D. Hagerman, J.V. Weil, and L.G. Moore, Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol, 1989;66(4):1656–1661.PubMedGoogle Scholar
  64. 64.
    Lyons, H.A. and R. Antonio, The sensitivity of the respiratory center in pregnancy and after the administration of progesterone. Trans Assoc Am Physicians, 1959;72:173–180.Google Scholar
  65. 65.
    Block, A.J., J.W. Wynne, P.G. Boysen, S. Lindsey, C. Martin, and B. Cantor, Menopause, medroxyprogesterone and breathing during sleep. Am J Med, 1981;70(3):506–510.PubMedCrossRefGoogle Scholar
  66. 66.
    Dolly, F.R. and A.J. Block, Medroxyprogesterone acetate and COPD. Effect on breathing and oxygenation in sleeping and awake patients. Chest, 1983;84(4):394–398.PubMedCrossRefGoogle Scholar
  67. 67.
    Orr, W.C., N.K. Imes, and R.J. Martin, Progesterone therapy in obese patients with sleep apnea. Arch Intern Med, 1979;139(1):109–111.PubMedCrossRefGoogle Scholar
  68. 68.
    Rajagopal, K.R., P.H. Abbrecht, and B. Jabbari, Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest, 1986;90(6):815–821.PubMedCrossRefGoogle Scholar
  69. 69.
    Skatrud, J.B., J.A. Dempsey, C. Iber, and A. Berssenbrugge, Correction of CO2 retention during sleep in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis, 1981;124(3):260–268.PubMedGoogle Scholar
  70. 70.
    Strohl, K.P., M.J. Hensley, N.A. Saunders, S.M. Scharf, R. Braun, and R.H. Ingram, Jr., Progesterone administration and progressive sleep apneas. JAMA, 1981;245(12):1230–1232.PubMedCrossRefGoogle Scholar
  71. 71.
    Rao, B.R., W.G. Wiest, and W.M. Allen, Progesterone “receptor” in rabbit uterus. I. Characterization and estradiol-17beta augmentation. Endocrinology, 1973;92(4):1229–1240.PubMedCrossRefGoogle Scholar
  72. 72.
    Brodeur, P., M. Mockus, R. McCullough, and L.G. Moore, Progesterone receptors and ventilatory stimulation by progestin. J Appl Physiol, 1986;60(2):590–595.PubMedGoogle Scholar
  73. 73.
    Keefe, D.L., R. Watson, and F. Naftolin, Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause, 1999;6(3):196–200.PubMedGoogle Scholar
  74. 74.
    Zeitlhofer, J., A. Schmeiser, G. Kapfhammer, J. Bolitschek, B. Saletu, and M. Keinze, Epidemiologie von Schlafstörungen in Osterreich. Neuropsychiatrie, 1996;10(1):43.Google Scholar
  75. 75.
    Rumbach, L., J. Krieger, and D. Kurtz, Auditory event-related potentials in obstructive sleep apnea: effects of treatment with nasal continuous positive airway pressure. Electroencephalogr Clin Neurophysiol, 1991; 80(5):454–457.PubMedCrossRefGoogle Scholar
  76. 76.
    Walsleben, J.A., E.B. O’Malley, K. Bonnet, R.G. Norman, and D.M. Rapoport, The utility of topographic EEG mapping in obstructive sleep apnea syndrome. Sleep, 1993;16(8 Suppl):S76–S78.PubMedGoogle Scholar
  77. 77.
    Partinen, M. and C. Guilleminault, Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest, 1990;97(1):27–32.PubMedCrossRefGoogle Scholar
  78. 78.
    Siebler, M. and A. Nachtmann, Cerebral hemodynamics in obstructive sleep apnea. Chest, 1993;103(4):1118–1119.PubMedCrossRefGoogle Scholar
  79. 79.
    Kales, A., A.B. Caldwell, R.J. Cadieux, A. Vela-Bueno, L.G. Ruch, and S.D. Mayes, Severe obstructive sleep apnea-II: Associated psychopathology and psychosocial consequences. J Chronic Dis, 1985;38(5):427–434.PubMedCrossRefGoogle Scholar
  80. 80.
    Millman, R.P., B.S. Fogel, M.E. McNamara, and C.C. Carlisle, Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry, 1989;50(9):348–351.PubMedGoogle Scholar
  81. 81.
    Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med, 2001;163(3 Pt 1):608–613.PubMedGoogle Scholar
  82. 82.
    Bixler, E.O., A.N. Vgontzas, H.M. Lin, et al., Association of hypertension and sleep-disordered breathing. Arch Intern Med, 2000;160(15):2289–2295.PubMedCrossRefGoogle Scholar
  83. 83.
    Campbell, S., Double-blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: Management of the Menopause and the Postmenopausal Years (S. Campbell, ed.). Lancaster: MTP Press, 1977:149–158.Google Scholar
  84. 84.
    Crown, S. and A.H. Crisp, Manual of the Crown-Crisp Experiential Index. London: Hodder and Stoughton, 1979.Google Scholar
  85. 85.
    Wiklund, I., G. Berg, M. Hammar, J. Karlberg, R. Lindgren, and K. Sandin, Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas, 1992;14(3):225–236.PubMedCrossRefGoogle Scholar
  86. 86.
    Saletu, B., P. Anderer, D. Gruber, M. Metka, J. Huber, and G. M. Saletu-Zyhlarz, Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone in menopausal syndrome patients. Maturitas, 2002;43(3):165–181.PubMedCrossRefGoogle Scholar
  87. 87.
    Anderer, P., H.V. Semlitsch, B. Saletu, et al., Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. Psychoneuroendocrinology, 2003;28(3):419–445.PubMedCrossRefGoogle Scholar
  88. 88.
    Linzmayer, L., H.V. Semlitsch, B. Saletu, et al., Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung, 2001;51(3):238–245.PubMedGoogle Scholar
  89. 89.
    Baumgartner, A., M. Dietzel, B. Saletu, et al., Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone, and estradiol in healthy young women. Psychiatry Res, 1993;48(2):153–178.PubMedCrossRefGoogle Scholar
  90. 90.
    Saletu, B. and G.M. Saletu-Zyhlarz, Was Sie Schon Immer Über Schlaf Wissen Wollten. 2001, Vienna: Ueberreuter.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2006

Authors and Affiliations

  • Gerda Saletu-Zyhlarz
    • 1
  • Peter Anderer
    • 1
  • Georg Gruber
    • 1
  • Markus Metka
    • 2
  • Johannes Huber
    • 2
  • Elisabeth Grätzhofer
    • 1
  • Bernd Saletu
    • 1
  1. 1.Department of PsychiatryUniversity of ViennaViennaAustria
  2. 2.Department of Gynecological EndocrinologyUniversity of ViennaViennaAustria

Personalised recommendations